Naproxen Sodium
NDC Package 62207-753-41

11-digit billing NDC: 62207075341
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Naproxen Sodium is temporarily relieves minor aches and pains due to:minor pain of arthritismuscular achesbackachemenstrual crampsheadachetoothachethe common coldtemporarily reduces fever. Marketed by Granules India Limited, this product is identified by NDC 62207-753 and is authorized under FDA application ANDA091353.

Identification & Billing

NDC Package Code
62207-753-41
Package Description
24 TABLET in 1 BOTTLE
Product Code
62207-753
11-Digit Billing Format
62207075341

Clinical Specifications

Proprietary Name
Naproxen Sodium
Dosage Form
-
Usage Information
Temporarily relieves minor aches and pains due to:minor pain of arthritismuscular achesbackachemenstrual crampsheadachetoothachethe common coldtemporarily reduces fever

Regulatory & Marketing

Labeler Name
Granules India Limited
FDA Application #
ANDA091353
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-2011
End Marketing Date
08-27-2019
Listing Expiration
08-27-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62207-753). Click a package code to view its specific billing and regulatory data.

62207-753-42
50 TABLET in 1 BOTTLE
62207-753-43
43 TABLET in 1 BOTTLE
62207-753-44
150 TABLET in 1 BOTTLE
62207-753-45
200 TABLET in 1 BOTTLE
62207-753-47
500 TABLET in 1 BOTTLE
62207-753-49
1000 TABLET in 1 BOTTLE
62207-753-51
10 TABLET in 1 BOTTLE
62207-753-52
300 TABLET in 1 BOTTLE
62207-753-53
400 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62207-753-41 identifies a specific commercial package of 24 tablet in 1 bottle of Naproxen Sodium, labeled by Granules India Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Granules India Limited on September 30, 2011. The current certification is valid through August 27, 2019.

How is this Granules India Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62207075341. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62207-753-41
11-Digit CMS (5-4-2)
62207-0753-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.